{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:05:20Z","timestamp":1648555520338},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herzschr. Elektrophys."],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00399-010-0084-z","type":"journal-article","created":{"date-parts":[[2010,6,17]],"date-time":"2010-06-17T17:32:11Z","timestamp":1276795931000},"page":"102-108","source":"Crossref","is-referenced-by-count":0,"title":["ICD-Therapie zur Prim\u00e4rpr\u00e4vention des pl\u00f6tzlichen Herztods"],"prefix":"10.1007","volume":"21","author":[{"given":"C.W.","family":"Israel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,16]]},"reference":[{"key":"84_CR1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.CIR.69.2.250","volume":"69","author":"Bigger","year":"1984","unstructured":"Bigger JT, Fleiss JL, Kleiger R et al. for the Multicenter Post-Infarction Research Group (1984) The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69:250\u2013258","journal-title":"Circulation"},{"key":"84_CR2","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","volume":"341","author":"Buxton","year":"1999","unstructured":"Buxton AE, Lee KL, Fisher JD et al (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882\u20131890","journal-title":"N Engl J Med"},{"key":"84_CR3","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jacc.2007.04.095","volume":"50","author":"Buxton","year":"2007","unstructured":"Buxton AE, Lee KL, Hafley GE et al (2007) Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 50:1150\u20131157","journal-title":"J Am Coll Cardiol"},{"key":"84_CR4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(96)08171-8","volume":"349","author":"Cairns","year":"1997","unstructured":"Cairns JA, Connolly SJ, Roberts R et al. for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial investigators (1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349:675\u2013682","journal-title":"Lancet"},{"key":"84_CR5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","author":"Cardiac","year":"1989","unstructured":"Cardiac Arrhythmias Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encanide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406\u2013412","journal-title":"N Engl J Med"},{"key":"84_CR6","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/01.CIR.60.6.1252","volume":"60","author":"Davis","year":"1979","unstructured":"Davis HT, DeCamilla J, Bayer LW et al (1979) Survivorship patterns in the posthospital phase of myocardial infarction. Circulation 60:1252\u20131258","journal-title":"Circulation"},{"key":"84_CR7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/clc.4960200808","volume":"20","author":"DIAMOND","year":"1997","unstructured":"DIAMOND Study Group (1997) Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patients characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality ON Dofetilide. Clin Cardiol 20:704\u2013710","journal-title":"Clin Cardiol"},{"key":"84_CR8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0735-1097(99)00327-7","volume":"34","author":"Domanski","year":"1999","unstructured":"Domanski MJ, Sakseena S, Epstein AE et al (1999) Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol 34:1090\u20131095","journal-title":"J Am Coll Cardiol"},{"key":"84_CR9","first-page":"e350","volume":"117","author":"Epstein","year":"2008","unstructured":"Epstein AE, DiMarco JP, Ellenbogen KA et al (2008) ACC\/AHA\/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 117:e350\u2013e408","journal-title":"Circulation"},{"key":"84_CR10","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1161\/CIRCULATIONAHA.105.577262","volume":"113","author":"Goldenberg","year":"2006","unstructured":"Goldenberg I, Moss AJ, Hall WJ et al (2006) Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation 113:2810\u20132817","journal-title":"Circulation"},{"key":"84_CR11","doi-asserted-by":"crossref","unstructured":"Goldenberg I, Vyas AK, Hall WJ et al (2008) Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 22;51(3):288\u2013296","DOI":"10.1016\/j.jacc.2007.08.058"},{"key":"84_CR12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2006.03.025","volume":"98","author":"Goldenberg","year":"2006","unstructured":"Goldenberg I, Moss AJ, McNitt S et al (2006) Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 98:485\u2013490","journal-title":"Am J Cardiol"},{"key":"84_CR13","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","volume":"351","author":"Hohnloser","year":"2004","unstructured":"Hohnloser SH, Kuck KH, Dorian P et al (2004) Prophylactic use of an implantable cardioverter \u2013 defibrillator after acute myocardial infarction. N Engl J Med 351:2481\u20132488","journal-title":"N Engl J Med"},{"key":"84_CR14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(96)09145-3","volume":"349","author":"Julian","year":"1997","unstructured":"Julian D, Camm AJ, Frangin G et al (1997) Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 349:667\u2013674","journal-title":"Lancet"},{"key":"84_CR15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00392-006-0475-7","volume":"95","author":"Jung","year":"2006","unstructured":"Jung W, Andresen D, Block M et al (2006) Leitlinien zur Implantation von Defibrillatoren. Clin Res Cardiol 95:696\u2013708","journal-title":"Clin Res Cardiol"},{"key":"84_CR16","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","volume":"333","author":"K\u00f8ber","year":"1995","unstructured":"K\u00f8ber L, Torp-Pedersen C, Carlsen JE et al (1995) A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333:1670\u20131676","journal-title":"N Engl J Med"},{"key":"84_CR17","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF","year":"1999","unstructured":"MERIT-HF Study Group (1999) Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001\u20132007","journal-title":"Lancet"},{"key":"84_CR18","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","volume":"335","author":"Moss","year":"1996","unstructured":"Moss AJ, Hall WJ, Cannom DS et al (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933\u20131940","journal-title":"N Engl J Med"},{"key":"84_CR19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"Moss","year":"2002","unstructured":"Moss AJ, Zareba W, Hall WJ et al. for the Multicenter Automatic Defibrillator Implantation Trial II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877\u2013883","journal-title":"N Engl J Med"},{"key":"84_CR20","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1161\/01.CIR.101.14.1638","volume":"101","author":"Moss","year":"2000","unstructured":"Moss AJ (2000) Implantable cardioverter defibrillator therapy: The sickest patients benefit the most. Circulation 101:1638\u20131640","journal-title":"Circulation"},{"key":"84_CR21","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1161\/01.CIR.0000150390.04704.B7","volume":"110","author":"Moss","year":"2004","unstructured":"Moss AJ, Greenberg H, Case RB et al (2004) Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110:3760\u20133765","journal-title":"Circulation"},{"key":"84_CR22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","volume":"361","author":"Moss","year":"2009","unstructured":"Moss AJ, Moss AJ, Hall WJ et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329\u20131338","journal-title":"N Engl J Med"},{"key":"84_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0002-9149(84)90299-6","volume":"54","author":"Mukharji","year":"1984","unstructured":"Mukharji J, Rude RE, Poole WK et al (1984) Risk factors for sudden death after acute myocardial infarction: two year follow-up. Am J Cardiol 54:31\u201336","journal-title":"Am J Cardiol"},{"key":"84_CR24","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"Pfeffer","year":"2003","unstructured":"Pfeffer MA, McMurray JJ, Velazquez EJ et al (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349:1893\u20131906","journal-title":"N Engl J Med"},{"key":"84_CR25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","volume":"359","author":"Poole","year":"2008","unstructured":"Poole JE, Johnson GW, Hellkamp AS et al (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009\u20131017","journal-title":"N Engl J Med"},{"key":"84_CR26","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.hrthm.2005.05.015","volume":"2","author":"Sharma","year":"2005","unstructured":"Sharma AD, Rizo-Patron C, Hallstrom AP et al (2005) Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2:830\u2013834","journal-title":"Heart Rhythm"},{"key":"84_CR27","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.101.14.1660","volume":"101","author":"Sheldon","year":"2000","unstructured":"Sheldon R, Connolly S, Krahn A et al (2000) Identification of patients most likely to benefit from ICD therapy: the Canadian Implantable Defibrillator Study. Circulation 101:1660\u20131664","journal-title":"Circulation"},{"key":"84_CR28","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1056\/NEJMoa043938","volume":"352","author":"Solomon","year":"2005","unstructured":"Solomon SD, Zelenkofske S, McMurray JJV et al (2005) Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352:2581\u20132588","journal-title":"N Engl J Med"},{"key":"84_CR29","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","volume":"361","author":"Steinbeck","year":"2009","unstructured":"Steinbeck G, Andresen D, Seidl K et al (2009) A randomized study of the effects of defibrillator implantation early after myocardial infarction in high-risk patients on optimal medical therapy. N Engl J Med 361:1427\u20131436","journal-title":"N Engl J Med"},{"key":"84_CR30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1540-8167.2005.50038.x","volume":"16","author":"Steinberg","year":"2005","unstructured":"Steinberg JS, Fischer A, Wang P et al (2005) The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II. J Cardiovasc Electrophysiol 16:359\u2013365","journal-title":"J Cardiovasc Electrophysiol"},{"key":"84_CR31","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1161\/01.CIR.0000145610.64014.E4","volume":"110","author":"Wathen","year":"2004","unstructured":"Wathen Wathen MS, DeGroot PJ, Sweeney MO et al (2004) Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 110:2591\u20132596","journal-title":"Circulation"},{"key":"84_CR32","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.0000121328.12536.07","volume":"109","author":"Wilber","year":"2004","unstructured":"Wilber DJ, Zareba W, Hall WJ et al (2004) Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 109:1082\u20131084","journal-title":"Circulation"},{"key":"84_CR33","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.288.24.3115","volume":"288","author":"Wilkoff","year":"2002","unstructured":"Wilkoff BL, Cook JR, Epstein AE et al (2002) Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288:3115\u20133123","journal-title":"JAMA"},{"key":"84_CR34","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/eurheartj\/ehi268","volume":"26","author":"Yap","year":"2005","unstructured":"Yap YG, Duong T, Bland M et al (2005) Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur Heart J 26:1385\u20131393","journal-title":"Eur Heart J"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-010-0084-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00399-010-0084-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-010-0084-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:16:43Z","timestamp":1559063803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00399-010-0084-z"}},"subtitle":["Der Patient nach Myokardinfarkt"],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1007\/s00399-010-0084-z","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}